It is reported that Sp1 overexpression predicts poor prognosis in some breast cancer patients while Jumonji domain-containing 2A-dependent inhibition Sp1 promotes metastasis in advanced breast cancer40,41. The gene discussed is KDM4A; the disease is breast cancer.